Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Quinagolide 50microgram tablets |
| Virtual Therapeutic Moiety | Quinagolide |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Combination product | Component only product |
| Prescribing status | Invalid to prescribe in NHS primary care |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Quinagolide hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395850005 |
| Strength value numerator | 50.000 |
| Strength value numerator unit | microgram |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Norprolac 50microgram tablets (Ferring Pharmaceuticals Ltd) | |
| Quinagolide 50microgram tablets (A A H Pharmaceuticals Ltd) | |
| Quinagolide 50microgram tablets (Alliance Healthcare (Distribution) Ltd) | |
| Quinagolide 50microgram tablets (Aspire Pharma Ltd) | |
| Quinagolide 50microgram tablets (Medihealth (Northern) Ltd) | |
| Virtual Medicinal Product Packs | |
| Quinagolide 50microgram tablets 3 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20251201000001, imported on 2nd December 2025 at 05:00:34.